Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 11 (3) , 245-252
- https://doi.org/10.1097/00008469-200206000-00008
Abstract
It has been shown that both serum vascular endothelial growth factor (VEGF) and also platelet counts are associated with survival in renal cell carcinoma (RCC). It is not known, however, whether VEGF in serum relates to the angiogenic activity of the tumour or is derived from circulating blood components. Therefore, the interrelation between serum VEGF, platelet and leukocyte counts compared with health history, clinicopathological findings and outcome was evaluated in patients with RCC. Blood samples were collected before nephrectomy in 161 patients. Serum VEGF165 was assessed by a quantitative ELISA method. Platelet and leukocyte counts were analysed routinely and obtained from medical records. The variables were compared using univariate and multivariate analysis. There were significant correlations between VEGF levels, and platelet (P PKeywords
This publication has 20 references indexed in Scilit:
- VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMAJournal of Urology, 2000
- Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell CarcinomaJapanese Journal of Cancer Research, 1999
- Vascular Endothelial Growth Factor Expression is Increased in Renal Cell CarcinomaJournal of Urology, 1997
- Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancerAnnals of Oncology, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Vascular permeability factor (VPF, VEGF) in tumor biologyCancer and Metastasis Reviews, 1993
- Risk factors for renal cell carcinoma: results of a population-based case-control studyCancer Causes & Control, 1993
- The Clinical Importance of Acquired Abnormalities of Platelet FunctionNew England Journal of Medicine, 1991
- Lymphocyte immunophenotyping in an elderly population: Age, sex and medication effects — a flow cytometry studyMechanisms of Ageing and Development, 1989
- A sex difference in the leucocyte countJournal of Clinical Pathology, 1968